Selective targeting of chemically modified miR-34a to prostate cancer using a small molecule ligand and an endosomal escape agent
Article in Molecular Therapy - Nucleic Acids (April 2024)
The most recent citing publications are shown below. View all 128 publications that cite this research output on Dimensions.
SKping cell cycle regulation: role of ubiquitin ligase SKP2 in hematological malignancies
Article in Frontiers in Oncology (March 2024)
Developing Folate-Conjugated miR-34a Therapeutic for Prostate Cancer: Challenges and Promises
Article in International Journal of Molecular Sciences (February 2024)